{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:29:25Z","timestamp":1790890165706,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Retinal vein occlusion (RVO) is the second commonest retinal vascular pathology, with macular edema (ME) as one of its major complications, which could finally cause vision loss. Anti-vascular endothelial growth factor (anti-VEGF therapy), as the standard therapy, has an unsustainable effect and needs repeated injections, which associates with frequent adverse events and significant economic burden. We reported a patient who had developed RVO and ME, and finally recovered after electroacupuncture treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 56-year-old woman complained a decrease of visual acuity in the right eye for 1 year. She received injection of 0.5\u200amg Conbercept, one of the anti-VEGF therapies, in the vitreous cavity 6 times in 1 year, and finally turned to acupuncture for help out of short-term effectiveness after each injection and high expenditure (CNY 40,800). No other severe medical history was reported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Under comprehensive consideration of clinical manifestations and the results of fluorescein fundus angiography and optical coherence tomography, the patient was diagnosed with hemi-RVO and ME.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient received electroacupuncture 3 sessions per week throughout 8 months (93 sessions in total).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The visual acuity of the patient was improved from 0.6 to 0.9 after the 8-month electroacupuncture treatment and remained stable during the 24-month follow-up; the central retinal thickness remained stable between 350 and 414 throughout the treatment and follow-up periods. Patients regarded the vision-related quality of life as satisfactory. The total expenditure of electroacupuncture treatment was CNY 6045. The patient did not receive any Conbercept injection over the whole period of 32\u200amonths. No relevant adverse events occurred.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Electroacupuncture might be effective in alleviating the symptoms of hemi-RVO-associated ME, with a potential of long-lasting effect. The frequency of anti-VEGF therapy could be reduced to the most extent, and the possibility of recurrence could be reduced as well, resulting good economic benefits.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028202","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T13:02:49Z","timestamp":1639746169000},"page":"e28202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Significant vision improvement and successful prevention of recurrence by electroacupuncture in hemiretinal vein occlusion combined with macular edema"],"prefix":"10.1097","volume":"100","author":[{"given":"Yan","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Acupuncture, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"New Zealand College of Chinese Medicine, Auckland, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7570-8917","authenticated-orcid":false,"given":"ZhiShun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Acupuncture, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group","volume":"98","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IAE.0b013e3182870c15","article-title":"Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature","volume":"33","author":"Jaulim","year":"2013","journal-title":"Retina"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ophtha.2019.09.029","article-title":"Retinal vein occlusions preferred practice Pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"R5-20250504","first-page":"CD009510","article-title":"Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion","author":"Mitry","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20250504","first-page":"123","volume":"242","author":"Schmidt-Erfurth","year":"2019","journal-title":"Guidelines for the management of retinal vein occlusion by the european society of retina specialists (EURETINA)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000320076","article-title":"Retinal vein occlusions","volume":"47","author":"Jonas","year":"2010","journal-title":"Dev Ophthalmol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/IAE.0b013e3182278ab4","article-title":"A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections","volume":"31","author":"van der Reis","year":"2011","journal-title":"Retina"},{"key":"R10-20250504","first-page":"625","article-title":"Analysis on literature of acupuncture and moxibustion treatment of intractable eye diseases","volume":"28","author":"Xu","year":"2008","journal-title":"Zhongguo Zhen Jiu"},{"key":"R11-20250504","first-page":"1888","article-title":"Research progress on the pathogenesis of macular edema secondary to retinal vein occlusion and the effect of macular edema on visual function","volume":"19","author":"Yong","year":"2019","journal-title":"Guoji Yanke Zazhi (Int Eye Sci)"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/eye.2015.164","article-title":"The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary","volume":"29","author":"Sivaprasad","year":"2015","journal-title":"Eye"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.2007.134874","article-title":"Predicted biological activity of intravitreal VEGF Trap","volume":"92","author":"Stewart","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/OPTH.S19555","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin\u00ae) in rabbits","volume":"5","author":"Sinapis","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.ophtha.2008.07.007","article-title":"Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?","volume":"115","author":"Schaal","year":"2008","journal-title":"Ophthalmology"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"06","DOI":"10.1159\/000381357","article-title":"Optimal treatment of retinal vein occlusion: Canadian expert consensus","volume":"234","author":"Berger","year":"2015","journal-title":"Ophthalmologica"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/IAE.0b013e3181a2c1c3","article-title":"Tachyphylaxis following intravitreal bevacizumab for exudative age-related macular degeneration","volume":"29","author":"Forooghian","year":"2009","journal-title":"Retina (Philadelphia, Pa)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bjo.2011.203893","article-title":"Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab","volume":"96","author":"Egh\u00f8j","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R20-20250504","first-page":"1241","article-title":"Effect of acupuncture on plasma fibrinogen in rabbit model of retinal vein occlusion","volume":"21","author":"Yan","year":"2010","journal-title":"Lishizhen Med Mater Med Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/JLB.3AB0420-361RR","article-title":"The neuro-immune microenvironment of acupoints \u2013 initiation of acupuncture effectiveness","volume":"108","author":"Gong","year":"2020","journal-title":"J Leukocyte Biol"},{"key":"R22-20250504","first-page":"726","article-title":"Effect of acupuncture on expression of transfer growth factor-\u03b21 in lacrimal gland of rabbits with dry eye","volume":"45","author":"Liu","year":"2020","journal-title":"Acupunct Res"},{"key":"R23-20250504","first-page":"64","article-title":"Effect of eye acupuncture on the changes of NF-\u03baB in rabbits with retinal vein occlusion","volume":"19","author":"Xu","year":"2017","journal-title":"J Liaoning Univ Tradit Chin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:18:45Z","timestamp":1746335925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028202"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":22,"journal-issue":{"issue":"50","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028202","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"2021-09-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}